Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Bernard

Showing results (191-200 of 199) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 199 results.
Rheumatology (Oxford, England)|March 17, 2023
Performance of the 2016 ACR-EULAR myositis response criteria in juvenile dermatomyositis therapeutic trials and consensus profilesHanna Kim, Didem Saygin, Christian Douglas, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 29, 2021
An MDS Evidence-Based Review on Treatments for Huntington's DiseaseJoaquim J Ferreira, Filipe B Rodrigues, Gonçalo S Duarte, et al.
Journal of Medicinal Chemistry|August 14, 2020
Structure-Based Design of a Bromodomain and Extraterminal Domain (BET) Inhibitor Selective for the N-Terminal Bromodomains That Retains an Anti-inflammatory and Antiproliferative PhenotypeChristopher R Wellaway, Paul Bamborough, Sharon G Bernard, et al.
Gaceta Medica De Mexico|August 22, 2008
[Social costs of the most common inflammatory rheumatic diseases in Mexico from the patient's perspective]Joaquín Mould-Quevedo, Ingris Peláez-Ballestas, Janitzia Vázquez-Mellado, et al.
Journal of Medicinal Chemistry|August 13, 2021
Discovery of a Novel Bromodomain and Extra Terminal Domain (BET) Protein Inhibitor, I-BET282E, Suitable for Clinical ProgressionKatherine L Jones, Dominic M Beaumont, Sharon G Bernard, et al.
Lancet (London, England)|December 10, 2015
Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trialNicolino Ruperto, Angela Pistorio, Sheila Oliveira, et al.
Journal of Child Neurology|July 29, 2020
Stress in Parents of Children With Genetically Determined Leukoencephalopathies: A Pilot StudyE Dermer, A Spahr, L T Tran, et al.
Clinical Genetics|August 19, 2015
Utility of whole-exome sequencing for those near the end of the diagnostic odyssey: time to address gaps in careS L Sawyer, T Hartley, D A Dyment, et al.
Nature Communications|January 23, 2026
De novo variants in the splicing factor gene SF3B1 are associated with neurodevelopmental disordersKevin Uguen, Tiffany Bergot, Marie-Pier Scott-Boyer, et al.
Pageof 20

Showing results (191-200 of 199) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 199 results.
Rheumatology (Oxford, England)|March 17, 2023
Performance of the 2016 ACR-EULAR myositis response criteria in juvenile dermatomyositis therapeutic trials and consensus profilesHanna Kim, Didem Saygin, Christian Douglas, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 29, 2021
An MDS Evidence-Based Review on Treatments for Huntington's DiseaseJoaquim J Ferreira, Filipe B Rodrigues, Gonçalo S Duarte, et al.
Journal of Medicinal Chemistry|August 14, 2020
Structure-Based Design of a Bromodomain and Extraterminal Domain (BET) Inhibitor Selective for the N-Terminal Bromodomains That Retains an Anti-inflammatory and Antiproliferative PhenotypeChristopher R Wellaway, Paul Bamborough, Sharon G Bernard, et al.
Gaceta Medica De Mexico|August 22, 2008
[Social costs of the most common inflammatory rheumatic diseases in Mexico from the patient's perspective]Joaquín Mould-Quevedo, Ingris Peláez-Ballestas, Janitzia Vázquez-Mellado, et al.
Journal of Medicinal Chemistry|August 13, 2021
Discovery of a Novel Bromodomain and Extra Terminal Domain (BET) Protein Inhibitor, I-BET282E, Suitable for Clinical ProgressionKatherine L Jones, Dominic M Beaumont, Sharon G Bernard, et al.
Lancet (London, England)|December 10, 2015
Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trialNicolino Ruperto, Angela Pistorio, Sheila Oliveira, et al.
Journal of Child Neurology|July 29, 2020
Stress in Parents of Children With Genetically Determined Leukoencephalopathies: A Pilot StudyE Dermer, A Spahr, L T Tran, et al.
Clinical Genetics|August 19, 2015
Utility of whole-exome sequencing for those near the end of the diagnostic odyssey: time to address gaps in careS L Sawyer, T Hartley, D A Dyment, et al.
Nature Communications|January 23, 2026
De novo variants in the splicing factor gene SF3B1 are associated with neurodevelopmental disordersKevin Uguen, Tiffany Bergot, Marie-Pier Scott-Boyer, et al.
Pageof 20